We are live on ! Find out more
Cannell & Co

Cannell & Co Portfolio holdings

AUM $3.15B Turnover 11.43%
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+11.95%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.58%
AUM
$3.15B
AUM Growth
+$229M
Cap. Flow
-$67.4M
Cap. Flow %
-2.14%
Top 10 Hldgs %
30.6%
Holding
280
New
21
Increased
58
Reduced
115
Closed
11
Avg Time Held
5.5 years
Top 10 Avg Time Held
3.2 years
Top 20 Avg Time Held
2.5 years

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$43.1M
2
LH icon
Labcorp
LH
+$27.4M
3
PINS icon
Pinterest
PINS
+$23.5M
4
GE icon
GE Aerospace
GE
+$18.2M
5
CSX icon
CSX
CSX
+$13.3M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$48.3M
2
VRT icon
Vertiv
VRT
+$31.6M
3
GPRE icon
Green Plains
GPRE
+$21.1M
4
KVUE icon
Kenvue
KVUE
+$19M
5
NTR icon
Nutrien
NTR
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 20.59%
2 Financials 15.93%
3 Industrials 13.18%
4 Healthcare 12.02%
5 Consumer Discretionary 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GDXJ icon
226
VanEck Junior Gold Miners ETF
GDXJ
$5.98B
$346K 0.01%
9,125
– –
2016 Q1
31 quarters
GILD icon
227
Gilead Sciences
GILD
$206B
$342K 0.01%
4,225
-200
-5% -$15.6K
2013 Q2
42 quarters
VLTO icon
228
Veralto
VLTO
$28.4B
$341K 0.01%
+4,151
New +$310K
2023 Q4
0 quarters
VXUS icon
229
Vanguard Total International Stock ETF
VXUS
$147B
$336K 0.01%
5,800
– –
2023 Q3
1 quarter
NOC icon
230
Northrop Grumman
NOC
$75.9B
$328K 0.01%
700
– –
2022 Q3
5 quarters
TSLA icon
231
Tesla
TSLA
$1.37T
$319K 0.01%
1,285
– –
2023 Q1
3 quarters
REYN icon
232
Reynolds Consumer Products
REYN
$5.13B
$306K 0.01%
11,400
– –
2020 Q3
13 quarters
CVS icon
233
CVS Health
CVS
$103B
$300K 0.01%
3,805
-335
-8% -$23.8K
2019 Q1
19 quarters
OEF icon
234
iShares S&P 100 ETF
OEF
$18.1B
$294K 0.01%
1,316
+2
+0.2% +$421
2022 Q4
4 quarters
AON icon
235
Aon
AON
$70.7B
$290K 0.01%
997
-525
-34% -$168K
2020 Q2
14 quarters
EL icon
236
Estee Lauder
EL
$36B
$282K 0.01%
1,925
-100
-5% -$13.3K
2018 Q2
22 quarters
KMI icon
237
Kinder Morgan
KMI
$67.6B
$273K 0.01%
15,484
– –
2014 Q3
37 quarters
XNCR icon
238
Xencor
XNCR
$2.5B
$267K 0.01%
+12,600
New +$240K
2023 Q4
0 quarters
LBAI icon
239
DELISTED
Lakeland Bancorp
LBAI
$266K 0.01%
18,000
– –
2020 Q2
14 quarters
SGRY icon
240
Surgery Partners
SGRY
$3.5B
$266K 0.01%
8,300
-76,670
-90% -$2.22M
2023 Q3
1 quarter
RY icon
241
Royal Bank of Canada
RY
$254B
$264K 0.01%
2,611
– –
2022 Q2
6 quarters
MA icon
242
Mastercard
MA
$545B
$245K 0.01%
575
– –
2023 Q3
1 quarter
STNG icon
243
Scorpio Tankers
STNG
$3.99B
$243K 0.01%
4,000
– –
2023 Q3
1 quarter
IWF icon
244
iShares Russell 1000 Growth ETF
IWF
$104B
$235K 0.01%
3,100
– –
2023 Q2
2 quarters
MNR icon
245
Mach Natural Resources
MNR
$1.35B
$231K 0.01%
+14,036
New +$243K
2023 Q4
0 quarters
IAUX icon
246
i-80 Gold
IAUX
$912M
$229K 0.01%
130,000
– –
2022 Q4
4 quarters
MSI icon
247
Motorola Solutions
MSI
$86B
$224K 0.01%
+717
New +$217K
2023 Q4
0 quarters
MPC icon
248
Marathon Petroleum
MPC
$100B
$223K 0.01%
1,500
– –
2023 Q3
1 quarter
IDXX icon
249
Idexx Laboratories
IDXX
$53.3B
$222K 0.01%
+400
New +$188K
2023 Q4
0 quarters
VLO icon
250
Valero Energy
VLO
$93.2B
$221K 0.01%
1,700
+200
+13% +$25.4K
2023 Q3
1 quarter

Similar funds

Cannell & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Cannell & Co held 280 positions worth $3.15B, up 7.8% from $2.92B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Cannell & Co's Q4 2023 filing shows 21 new, 58 increased, 115 reduced and 11 closed positions. Its largest new stake was CRH: 714,012 shares worth $49.4M. The largest sale was Humana, an estimated $48.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Cannell & Co's largest Q4 2023 buy was CRH: 714,012 shares worth $49.4M.
  • Cannell & Co added most to Labcorp in Q4 2023, an estimated $27.4M increase.
  • Cannell & Co's biggest Q4 2023 reduction was Humana, cutting an estimated $48.3M.
  • Cannell & Co fully exited Nutrien in Q4 2023, selling an estimated $14.4M.
  • Cannell & Co's ten largest holdings make up 31% of its $3.15B portfolio in Q4 2023.
  • Cannell & Co opened 21 new positions and closed 11 in Q4 2023.
  • Cannell & Co's portfolio value rose 7.8% quarter-over-quarter to $3.15B.

Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.